Drug Companies Sued For Medical Care For Opioid-Addicted Infants

(August 29, 2018, 10:32 AM EDT) -- PHILADELPHIA — A class complaint filed Aug. 24 in a Pennsylvania federal court seeks from leading drug companies medical testing, monitoring and intervention for babies and children diagnosed at birth with opioid-related neonatal abstinence syndrome (NAS) (John Doe, et al. v. Purdue Pharma L.P., et al., No. 18-3637, E.D. Pa.)....

Attached Documents

Related Sections